Clinical Trial Update: Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adherence to Glucophage sachets versus metformin tablets in type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage (metformin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: WITHDRAWN